Home » Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules to be Selected for Guangdong Alliance Drug Collection_ Securities Times Network

Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules to be Selected for Guangdong Alliance Drug Collection_ Securities Times Network

by admin
Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules to be Selected for Guangdong Alliance Drug Collection_ Securities Times Network
</p> <p> Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules to be Selected for Guangdong Alliance Drug Collection_ Securities Times Network<br />

Home > News > e company

Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules are to be selected for the Guangdong Alliance Drug Collection

2022-03-11 16:28

Source: Securities Times e Company

Author: Lee Jae-san

Securities Times · e company

Lee Jae-san

2022-03-11 16:28

Securities Times e Company News, Rundu Co., Ltd. (002923) announced on the evening of March 11, according to the announcement of the Guangdong Alliance Diclofenac and other drugs in the centralized and bulk procurement (the first batch) announced by the Guangdong Provincial Drug Trading Center. , the company’s product rabeprazole sodium enteric-coated capsules (registered trademark: Yutianqing) is planned to be selected for this centralized procurement.

Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.

  • Securities Times APP
  • WeChat public account


  • 4230266

    Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules are to be selected for the Guangdong Alliance Drug Collection

    6885

    e company

    news

    1445

    Lee Jae-san

    2022-03-11

    See also  Three major U.S. stock indexes mixed up and down, Nasdaq hit a record high

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy